Press-release for stocks related to cancer for amgen inc.

tags : Cancer entities : Amgen inc.

save search

Chemotherapy Induced Peripheral Neuropathy Treatment Market Projected Strong Growth to $2.25 Billion by 2028 Amid Advancements in Cancer Treatment
Published: 2024-03-07 (Crawled : 00:00) - prnewswire.com
ABT | News | $105.27 -0.6% -0.15% 7.3M

Health Technology

| -8.86% | O: 1.41% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -2.59% | O: 1.62% H: 0.0% C: 0.0%
QDEL M | $38.28 -1.11% -1.12% 1M

Health Technology

| -9.7% | O: 1.14% H: 4.36% C: 3.16%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| -3.49% | O: -0.1% H: 0.18% C: -1.25%
cancer treatment growth market

Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

Health Technology

| -5.87% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -3.13% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | $140.15 -4.19% 560

Health Technology

| 6.54% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | $93.6375 6.88% 82K

Health Technology

| -8.14% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $64.07 -4.38% 72K

Manufacturing

| 25.87% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | $9.46 -1.11% 500K

Manufacturing

| -16.01% | O: -0.27% H: 0.0% C: -1.17%
TAK | News | $13.16 0.08% 0.0% 1.3M

Health Technology

| -10.79% | O: -0.2% H: 0.14% C: -0.48%
NVS | $92.57 -0.55% 0.0% 910K

Health Technology

| -9.24% | O: -0.06% H: 0.46% C: 0.29%
GSK | $39.27 -0.83% 0.01% 2.2M

Health Technology

| -5.58% | O: -0.69% H: 1.42% C: 1.22%
LLY | $745.95 -0.64% -0.1% 1.7M

Health Technology

| 0.65% | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.3 0.96% -0.1% 11M

Health Technology

| -5.21% | O: -0.65% H: 1.63% C: 1.48%
ABBV | News | $164.66 0.25% -0.15% 4.5M

Health Technology

| -7.04% | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -2.16% | O: 1.67% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

Health Technology

| 4.88% | O: -2.81% H: 2.08% C: 1.38%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| -5.83% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published: 2024-02-19 (Crawled : 16:00) - prnewswire.com
BIIB | $190.55 -0.84% -0.84% 1.5M

Health Technology

| Email alert Add to watchlist
VTRS | $11.11 0.09% 0.09% 3.5M

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K

Health Technology

| Email alert Add to watchlist
AZN | $68.36 -0.25% -0.25% 4M

Health Technology

| Email alert Add to watchlist
GLAXF | $20.2 -14.18% 510

Health Technology

| Email alert Add to watchlist
GSK | $39.27 -0.83% 0.01% 2.2M

Health Technology

| Email alert Add to watchlist
AZNCF | $140.15 -4.19% 560

Health Technology

| Email alert Add to watchlist
JAZZ | $109.3 2.05% 2.01% 560K

Health Technology

| Email alert Add to watchlist
NVS | $92.57 -0.55% 0.0% 910K

Health Technology

| Email alert Add to watchlist
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| Email alert Add to watchlist
cancer cell global growth market

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K

Health Technology

| -13.72% | O: -1.53% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560

Health Technology

| 1.09% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

Health Technology

| -8.98% | O: 0.41% H: 0.0% C: 0.0%
UCBJY | $64.07 -4.38% 72K

Manufacturing

| 37.02% | O: 1.71% H: 1.28% C: 0.94%
ALPMY | $9.46 -1.11% 500K

Manufacturing

| -14.23% | O: 0.28% H: 0.18% C: 0.0%
TAK | News | $13.16 0.08% 0.0% 1.3M

Health Technology

| -7.13% | O: 0.07% H: 0.42% C: 0.07%
NVS | $92.57 -0.55% 0.0% 910K

Health Technology

| -10.28% | O: 0.09% H: 0.39% C: -0.36%
JNJ | News | $145.74 0.67% 0.0% 9.3M

Health Technology

| -7.04% | O: 1.47% H: 0.0% C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M

Health Technology

| 6.49% | O: 0.76% H: 4.31% C: 2.11%
BMY | $48.3 0.96% -0.1% 11M

Health Technology

| -2.03% | O: -0.14% H: 0.35% C: -1.12%
ABBV | News | $164.66 0.25% -0.15% 4.5M

Health Technology

| -4.15% | O: 1.48% H: 0.0% C: 0.0%
VRTX | News | $393.51 0.1% 0.1% 950K

Health Technology

| -5.53% | O: 0.15% H: 2.4% C: 0.56%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -0.9% | O: 1.33% H: 0.0% C: 0.0%
JAZZ | $109.3 2.05% 2.01% 560K

Health Technology

| -14.12% | O: -0.02% H: 0.0% C: -1.4%
AZN | $68.36 -0.25% -0.25% 4M

Health Technology

| 1.83% | O: -0.4% H: 0.19% C: -0.33%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| -15.55% | O: -0.18% H: 0.0% C: -6.22%
report cancer blood growth market

Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

Health Technology

| 4.69% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | $140.15 -4.19% 560

Health Technology

| 3.09% | O: 3.41% H: 0.0% C: -2.45%
VTRS | $11.11 0.09% 0.09% 3.5M

Health Technology

| -6.01% | O: -0.08% H: 3.47% C: -0.25%
NVS | $92.57 -0.55% 0.0% 910K

Health Technology

| -13.61% | O: -2.04% H: 0.19% C: -1.97%
GSK | $39.27 -0.83% 0.01% 2.2M

Health Technology

| 1.3% | O: 4.04% H: 1.57% C: -3.02%
ABBV | News | $164.66 0.25% -0.15% 4.5M

Health Technology

| -0.6% | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -8.28% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $4.98 -3.68% -3.82% 290K

Health Technology

| 8.5% | O: -0.1% H: 2.31% C: -1.26%
AZN | $68.36 -0.25% -0.25% 4M

Health Technology

| 1.58% | O: 0.82% H: 0.12% C: -1.64%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| -15.16% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

Castration-Resistant Prostate Cancer (CRPC) Treatment Market size to grow by USD 5.98 billion from 2023 to 2028, North America to account for 47% of market growth- Technavio
Published: 2024-01-09 (Crawled : 03:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K

Health Technology

| -22.38% | O: 0.16% H: 0.0% C: -3.88%
NVSEF | $93.6375 6.88% 82K

Health Technology

| -11.87% | O: -0.24% H: 0.0% C: 0.0%
ALPMY | $9.46 -1.11% 500K

Manufacturing

| -23.94% | O: -1.22% H: 0.0% C: -0.72%
NVS | $92.57 -0.55% 0.0% 910K

Health Technology

| -13.07% | O: -0.46% H: 0.74% C: -0.19%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -10.52% | O: 0.74% H: 0.0% C: 0.0%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| -14.14% | O: -0.92% H: 0.63% C: -0.25%
america cancer treatment market

Cancer Immunotherapy Market to grow by USD 38.57 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio
Published: 2024-01-04 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

Health Technology

| 3.48% | O: 2.46% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -8.98% | O: 0.49% H: 0.6% C: -0.83%
AZNCF | $140.15 -4.19% 560

Health Technology

| -1.27% | O: 0.15% H: 1.88% C: -1.17%
NVSEF | $93.6375 6.88% 82K

Health Technology

| -10.82% | O: -0.24% H: 1.43% C: 1.43%
NVS | $92.57 -0.55% 0.0% 910K

Health Technology

| -11.83% | O: 0.32% H: 0.93% C: 0.38%
GSK | $39.27 -0.83% 0.01% 2.2M

Health Technology

| 1.36% | O: -0.36% H: 0.98% C: 0.72%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -9.61% | O: -0.14% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

Health Technology

| -0.75% | O: -0.68% H: 0.87% C: 0.1%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| -11.95% | O: -0.32% H: 0.44% C: 0.26%
america cancer immunotherapy market

Global Cancer Immunotherapy Market Poised to Exceed US$ 188 Billion by 2030, with CAGR of 10.02%
Published: 2023-12-14 (Crawled : 01:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K

Health Technology

| -6.65% | O: -1.67% H: 1.17% C: 0.85%
JNJ | News | $145.74 0.67% 0.0% 9.3M

Health Technology

| -5.84% | O: 1.81% H: 0.0% C: 0.0%
BMY | $48.3 0.96% -0.1% 11M

Health Technology

| -6.94% | O: 1.16% H: 0.14% C: -1.89%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| -5.21% | O: -0.11% H: 0.5% C: -1.78%
cancer global immunotherapy market

FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer
Published: 2023-12-13 (Crawled : 21:00) - prnewswire.com
BGNE | $131.94 0.06% 0.06% 130K

Health Technology

| -26.88% | O: 0.91% H: 2.03% C: 1.4%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| -5.21% | O: -0.11% H: 0.5% C: -1.78%
fda lung review cancer cell application grants advanced

US Kidney Cancer Therapeutics and Diagnostics Market to 2028, Featuring Profiles of Amgen, Hoffman-La Roche, Bayer, Pfizer, Bristol Myers Squibb and Novartis
Published: 2023-12-12 (Crawled : 01:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

Health Technology

| -2.46% | O: 1.56% H: 0.51% C: 0.51%
NVS | $92.57 -0.55% 0.0% 910K

Health Technology

| -4.32% | O: 0.45% H: 0.75% C: 0.46%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| -1.91% | O: 1.83% H: 0.04% C: -1.13%
kidney cancer novartis diagnostics therapeutics market

Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC and more among the key companies in the market - Technavio
Published: 2023-12-05 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

Health Technology

| 14.06% | O: 1.64% H: 0.0% C: -1.33%
AZNCF | $140.15 -4.19% 560

Health Technology

| 7.6% | O: 1.51% H: 0.13% C: -1.68%
NVS | $92.57 -0.55% 0.0% 910K

Health Technology

| -4.01% | O: 0.52% H: 0.18% C: -0.43%
GSK | $39.27 -0.83% 0.01% 2.2M

Health Technology

| 9.0% | O: -0.03% H: 0.28% C: -0.41%
BAX | $39.65 0.33% 0.0% 2.3M

Health Technology

| 10.89% | O: 0.14% H: 0.78% C: 0.22%
ABBV | News | $164.66 0.25% -0.15% 4.5M

Health Technology

| 13.39% | O: 0.26% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

Health Technology

| 6.65% | O: 0.73% H: 0.06% C: -1.38%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| -1.45% | O: 0.2% H: 0.2% C: -0.76%
GOOGL | News S | $155.97 0.32% 0.32% 19M

Technology Services

| 20.52% | O: 1.97% H: 0.0% C: 0.0%
GOOG | News S | $157.49 0.39% 0.39% 14M

Technology Services

| 20.33% | O: 1.97% H: 0.0% C: 0.0%
ADBE M | $472.91 -0.33% -0.33% 2.4M

Technology Services

| -20.92% | O: 0.97% H: 0.08% C: -2.03%
tube companies abbvie cancer pharmaceuticals therapeutics market

Laryngeal Cancer Therapeutics Market size to grow by USD 575.25 million from 2022-2027| Accord Healthcare Ltd., Amgen Inc., AstraZeneca Plc, Athenex Inc. and more among the major companies in the market- Technavio
Published: 2023-12-01 (Crawled : 23:00) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| Email alert Add to watchlist
AZN | $68.36 -0.25% -0.25% 4M

Health Technology

| Email alert Add to watchlist
AZNCF | $140.15 -4.19% 560

Health Technology

| Email alert Add to watchlist
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| Email alert Add to watchlist
companies astrazeneca cancer therapeutics market

Increasing Prevalence of Laryngeal Cancer Fuels Growth in Laryngeal Cancer Therapeutics Market
Published: 2023-10-27 (Crawled : 02:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -11.93% | O: -18.18% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560

Health Technology

| 8.01% | O: -1.1% H: 0.18% C: -1.98%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -13.23% | O: -15.73% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

Health Technology

| 7.66% | O: -0.42% H: 0.13% C: -1.99%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| -1.03% | O: -0.28% H: 0.15% C: -2.74%
cancer therapeutics growth market

AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER
Published: 2023-10-22 (Crawled : 16:20) - prnewswire.com
CCXI | $51.99 -0.04%

Health Technology

| Email alert Add to watchlist
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| Email alert Add to watchlist
BGNE | $131.94 0.06% 0.06% 130K

Health Technology

| Email alert Add to watchlist
BEIGF | $14.29 -9.87% 2.1K

n/a

| Email alert Add to watchlist
lumakras cancer plus

AMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER
Published: 2023-10-20 (Crawled : 12:00) - prnewswire.com
BGNE | $131.94 0.06% 0.06% 130K

Health Technology

| -15.52% | O: -1.33% H: 5.87% C: 5.53%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| -4.87% | O: 0.0% H: 0.16% C: -0.64%
lung cancer cell

Minimal Residual Disease Testing Global Markets and Technology Research Report 2023-2028: Charting Cancer Treatment Trajectories - The Role of MRD Explored
Published: 2023-08-25 (Crawled : 14:30) - prnewswire.com
AZNCF | $140.15 -4.19% 560

Health Technology

| -0.51% | O: -3.27% H: 3.65% C: 3.36%
AZN | $68.36 -0.25% -0.25% 4M

Health Technology

| 0.55% | O: 0.22% H: 0.6% C: 0.31%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| 4.02% | O: 0.19% H: 0.25% C: -0.28%
disease report cancer treatment research global technology

Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published: 2023-06-08 (Crawled : 02:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560

Health Technology

| -7.89% | O: 0.07% H: 0.0% C: -1.7%
NVSEF | $93.6375 6.88% 82K

Health Technology

| 14.25% | O: 1.32% H: 0.0% C: -0.62%
TAK | News | $13.16 0.08% 0.0% 1.3M

Health Technology

| -18.27% | O: -0.62% H: 0.88% C: 0.81%
NVS | $92.57 -0.55% 0.0% 910K

Health Technology

| -5.5% | O: 1.26% H: 1.08% C: 0.91%
GSK | $39.27 -0.83% 0.01% 2.2M

Health Technology

| 15.25% | O: 0.41% H: 0.68% C: 0.64%
LLY | $745.95 -0.64% -0.1% 1.7M

Health Technology

| 72.05% | O: -0.11% H: 2.66% C: 2.24%
BMY | $48.3 0.96% -0.1% 11M

Health Technology

| -25.94% | O: 0.28% H: 0.42% C: -0.05%
BNTX | $86.19 -0.24% -0.24% 580K

Health Technology

| -21.09% | O: 0.39% H: 0.15% C: -0.79%
AZN | $68.36 -0.25% -0.25% 4M

Health Technology

| -6.88% | O: -0.23% H: 1.83% C: 1.52%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| 20.65% | O: 0.0% H: 0.28% C: -0.23%
metabolic report cancer global therapeutics growth market

Global Blood Cancer Drugs Market Report 2023: Increasing Prevalence of Blood Cancer Cases Drives Growth
Published: 2023-05-16 (Crawled : 22:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560

Health Technology

| -10.51% | O: -1.32% H: 0.92% C: -1.34%
JNJ | News | $145.74 0.67% 0.0% 9.3M

Health Technology

| -9.14% | O: 0.28% H: 0.17% C: -0.5%
BMY | $48.3 0.96% -0.1% 11M

Health Technology

| -27.99% | O: 0.06% H: 0.43% C: -0.79%
ABBV | News | $164.66 0.25% -0.15% 4.5M

Health Technology

| 14.4% | O: -0.19% H: 0.35% C: 0.23%
AZN | $68.36 -0.25% -0.25% 4M

Health Technology

| -9.32% | O: 0.07% H: 0.03% C: -0.84%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| 17.14% | O: -0.82% H: 0.03% C: -0.44%
report cancer blood global growth market

Targeted Therapy Global Market Report 2023: Increasing Prevalence of Cancer Drives Growth
Published: 2023-05-15 (Crawled : 17:00) - prnewswire.com
GNMSF | $281.02 3.83% 210

Health Technology

| -33.14% | O: 0.24% H: 0.66% C: 0.66%
NVSEF | $93.6375 6.88% 82K

Health Technology

| 7.89% | O: -1.1% H: 0.0% C: 0.0%
TAK | News | $13.16 0.08% 0.0% 1.3M

Health Technology

| -19.72% | O: 0.61% H: 0.3% C: 0.24%
NVS | $92.57 -0.55% 0.0% 910K

Health Technology

| -9.75% | O: 0.2% H: 0.13% C: -0.22%
GSK | $39.27 -0.83% 0.01% 2.2M

Health Technology

| 8.4% | O: 0.27% H: 0.6% C: 0.41%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -14.75% | O: 0.38% H: 0.0% C: 0.0%
GMAB | $28.32 -0.74% -0.74% 240K

Health Technology

| -31.57% | O: 0.38% H: 0.91% C: 0.69%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| 14.59% | O: 0.14% H: 0.28% C: 0.11%
report cancer global therapy growth market

Breast cancer therapeutics market size grow by USD 13.85 billion between 2021 to 2026; AbbVie Inc. and Amgen Inc., among others, emerge as key vendors - Technavio
Published: 2023-04-13 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

Health Technology

| 8.89% | O: 0.54% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| -18.15% | O: -1.1% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560

Health Technology

| -8.11% | O: 0.0% H: 1.63% C: 1.63%
NVSEF | $93.6375 6.88% 82K

Health Technology

| 16.68% | O: 1.25% H: 0.51% C: 0.51%
VTRS | $11.11 0.09% 0.09% 3.5M

Health Technology

| 13.03% | O: 0.31% H: 1.42% C: 0.71%
NVS | $92.57 -0.55% 0.0% 910K

Health Technology

| -3.51% | O: 1.3% H: 0.56% C: 0.51%
GSK | $39.27 -0.83% 0.01% 2.2M

Health Technology

| 5.01% | O: 0.85% H: 0.76% C: 0.76%
ABBV | News | $164.66 0.25% -0.15% 4.5M

Health Technology

| 0.96% | O: -0.84% H: 1.16% C: 1.05%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -17.54% | O: 0.29% H: 0.0% C: 0.0%
PBYI | $4.98 -3.68% -3.82% 290K

Health Technology

| 77.66% | O: -0.34% H: 10.17% C: 6.9%
AZN | $68.36 -0.25% -0.25% 4M

Health Technology

| -7.45% | O: 0.39% H: 1.05% C: 0.97%
AMGN | $262.77 -0.49% -0.49% 2M

Health Technology

| 6.99% | O: -0.36% H: 1.33% C: 1.14%
abbvie breast cancer therapeutics market

← Previous
1
2
3
4
5
Next →

tags : Cancer entities : Amgen inc.

save search

Gainers vs Losers

Top 10 Gainers

Your saved searches

tags : Cancer entities : Amgen inc. save search

Gainers vs Losers

Top 10 Gainers

Your saved searches

tags : Cancer entities : Amgen inc.

save search